nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—RXRA—thyroid cancer	0.806	1	CbGaD
Adapalene—RXRG—neck—thyroid cancer	0.00392	0.157	CbGeAlD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00362	0.028	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00331	0.0256	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00324	0.0251	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00311	0.0241	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00311	0.0241	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.0029	0.0225	CbGpPWpGaD
Adapalene—RXRB—Vitamin D Metabolism—RXRA—thyroid cancer	0.00284	0.022	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00273	0.0211	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—THRB—thyroid cancer	0.00267	0.0207	CbGpPWpGaD
Adapalene—Herpes labialis—Epirubicin—thyroid cancer	0.00262	0.066	CcSEcCtD
Adapalene—RXRG—Nuclear Receptors—THRB—thyroid cancer	0.00244	0.0189	CbGpPWpGaD
Adapalene—Herpes labialis—Doxorubicin—thyroid cancer	0.00242	0.0611	CcSEcCtD
Adapalene—RARB—Nuclear Receptors—THRB—thyroid cancer	0.00239	0.0185	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—THRB—thyroid cancer	0.00229	0.0178	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—THRB—thyroid cancer	0.00229	0.0178	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00211	0.0163	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00193	0.0149	CbGpPWpGaD
Adapalene—RARB—thyroid gland—thyroid cancer	0.00191	0.0763	CbGeAlD
Adapalene—RARB—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00189	0.0146	CbGpPWpGaD
Adapalene—RXRA—head—thyroid cancer	0.00188	0.0754	CbGeAlD
Adapalene—RXRG—thyroid gland—thyroid cancer	0.00186	0.0746	CbGeAlD
Adapalene—RXRB—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00181	0.014	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00181	0.014	CbGpPWpGaD
Adapalene—RXRB—thyroid gland—thyroid cancer	0.00175	0.0702	CbGeAlD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—LAMA2—thyroid cancer	0.00174	0.0135	CbGpPWpGaD
Adapalene—RARB—head—thyroid cancer	0.00169	0.0677	CbGeAlD
Adapalene—RXRG—head—thyroid cancer	0.00165	0.0662	CbGeAlD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—LAMA2—thyroid cancer	0.00163	0.0126	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00162	0.0125	CbGpPWpGaD
Adapalene—Oral herpes—Epirubicin—thyroid cancer	0.00161	0.0406	CcSEcCtD
Adapalene—RARG—thyroid gland—thyroid cancer	0.00156	0.0623	CbGeAlD
Adapalene—RXRB—head—thyroid cancer	0.00156	0.0622	CbGeAlD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00154	0.0119	CbGpPWpGaD
Adapalene—Oral herpes—Doxorubicin—thyroid cancer	0.00149	0.0376	CcSEcCtD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00148	0.0114	CbGpPWpGaD
Adapalene—RARA—thyroid gland—thyroid cancer	0.00146	0.0586	CbGeAlD
Adapalene—RXRA—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00142	0.011	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.0014	0.0109	CbGpPWpGaD
Adapalene—RARG—head—thyroid cancer	0.00138	0.0552	CbGeAlD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00138	0.0107	CbGpPWpGaD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00137	0.0106	CbGpPWpGaD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00135	0.0104	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00132	0.0102	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00132	0.0102	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00132	0.0102	CbGpPWpGaD
Adapalene—RARA—head—thyroid cancer	0.0013	0.0519	CbGeAlD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00127	0.00982	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00127	0.00982	CbGpPWpGaD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00125	0.0097	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00123	0.00951	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—THRB—thyroid cancer	0.0012	0.00926	CbGpPWpGaD
Adapalene—RARB—lymph node—thyroid cancer	0.00119	0.0474	CbGeAlD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00118	0.00912	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00118	0.00912	CbGpPWpGaD
Adapalene—Dermatitis bullous—Vandetanib—thyroid cancer	0.00116	0.0292	CcSEcCtD
Adapalene—RARG—Nuclear Receptors—RXRA—thyroid cancer	0.00113	0.00877	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptors—RXRA—thyroid cancer	0.00104	0.00803	CbGpPWpGaD
Adapalene—RARG—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.00103	0.00795	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—RXRA—thyroid cancer	0.00102	0.00787	CbGpPWpGaD
Adapalene—Dry skin—Vandetanib—thyroid cancer	0.00101	0.0256	CcSEcCtD
Adapalene—Skin exfoliation—Sorafenib—thyroid cancer	0.000981	0.0247	CcSEcCtD
Adapalene—RARA—Nuclear Receptors—RXRA—thyroid cancer	0.000975	0.00755	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—RXRA—thyroid cancer	0.000975	0.00755	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.00097	0.00751	CbGpPWpGaD
Adapalene—RARG—lymph node—thyroid cancer	0.000967	0.0387	CbGeAlD
Adapalene—RXRA—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.000945	0.00731	CbGpPWpGaD
Adapalene—RXRG—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000939	0.00727	CbGpPWpGaD
Adapalene—RARB—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000921	0.00713	CbGpPWpGaD
Adapalene—RARA—lymph node—thyroid cancer	0.000909	0.0364	CbGeAlD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—RXRA—thyroid cancer	0.000906	0.00701	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000896	0.00693	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000887	0.00686	CbGpPWpGaD
Adapalene—RXRB—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000883	0.00684	CbGpPWpGaD
Adapalene—RARA—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000883	0.00684	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Vandetanib—thyroid cancer	0.000872	0.022	CcSEcCtD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.00087	0.00673	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—RXRA—thyroid cancer	0.000852	0.00659	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—LAMA2—thyroid cancer	0.000852	0.00659	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000834	0.00645	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000834	0.00645	CbGpPWpGaD
Adapalene—Eczema—Sorafenib—thyroid cancer	0.00083	0.0209	CcSEcCtD
Adapalene—Conjunctivitis—Vandetanib—thyroid cancer	0.000828	0.0209	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000819	0.00634	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000804	0.00622	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.000795	0.00615	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00079	0.0199	CcSEcCtD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000782	0.00606	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00077	0.00596	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00077	0.00596	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.000747	0.00578	CbGpPWpGaD
Adapalene—RXRA—PPAR Alpha Pathway—CDK1—thyroid cancer	0.000742	0.00574	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—PPARG—thyroid cancer	0.000716	0.00554	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000702	0.00543	CbGpPWpGaD
Adapalene—Dry skin—Sorafenib—thyroid cancer	0.000683	0.0172	CcSEcCtD
Adapalene—Vesiculobullous rash—Epirubicin—thyroid cancer	0.000677	0.0171	CcSEcCtD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000673	0.00521	CbGpPWpGaD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.000661	0.00512	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptors—PPARG—thyroid cancer	0.000655	0.00507	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—PPARG—thyroid cancer	0.000642	0.00497	CbGpPWpGaD
Adapalene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFA13—thyroid cancer	0.000629	0.00487	CbGpPWpGaD
Adapalene—Vesiculobullous rash—Doxorubicin—thyroid cancer	0.000627	0.0158	CcSEcCtD
Adapalene—Optic neuritis—Epirubicin—thyroid cancer	0.000617	0.0156	CcSEcCtD
Adapalene—RARA—Nuclear Receptors—PPARG—thyroid cancer	0.000616	0.00476	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—PPARG—thyroid cancer	0.000616	0.00476	CbGpPWpGaD
Adapalene—Keratitis—Epirubicin—thyroid cancer	0.000585	0.0148	CcSEcCtD
Adapalene—Convulsion—Vandetanib—thyroid cancer	0.000577	0.0145	CcSEcCtD
Adapalene—Optic neuritis—Doxorubicin—thyroid cancer	0.000571	0.0144	CcSEcCtD
Adapalene—RARG—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000566	0.00438	CbGpPWpGaD
Adapalene—Redness—Epirubicin—thyroid cancer	0.000562	0.0142	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Epirubicin—thyroid cancer	0.000557	0.014	CcSEcCtD
Adapalene—Burning sensation—Epirubicin—thyroid cancer	0.000546	0.0138	CcSEcCtD
Adapalene—Keratitis—Doxorubicin—thyroid cancer	0.000542	0.0137	CcSEcCtD
Adapalene—Redness—Doxorubicin—thyroid cancer	0.00052	0.0131	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000517	0.004	CbGpPWpGaD
Adapalene—Seborrhoeic dermatitis—Doxorubicin—thyroid cancer	0.000515	0.013	CcSEcCtD
Adapalene—Dermatitis atopic—Epirubicin—thyroid cancer	0.000513	0.0129	CcSEcCtD
Adapalene—RARB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000507	0.00393	CbGpPWpGaD
Adapalene—Burning sensation—Doxorubicin—thyroid cancer	0.000506	0.0128	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000504	0.0039	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.000497	0.00384	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000486	0.00376	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000486	0.00376	CbGpPWpGaD
Adapalene—Feeling hot—Epirubicin—thyroid cancer	0.000484	0.0122	CcSEcCtD
Adapalene—Rash pustular—Epirubicin—thyroid cancer	0.000476	0.012	CcSEcCtD
Adapalene—Dermatitis atopic—Doxorubicin—thyroid cancer	0.000475	0.012	CcSEcCtD
Adapalene—Stinging—Epirubicin—thyroid cancer	0.000469	0.0118	CcSEcCtD
Adapalene—Pain—Vandetanib—thyroid cancer	0.000465	0.0117	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000461	0.00357	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000452	0.0035	CbGpPWpGaD
Adapalene—Erythema—Sorafenib—thyroid cancer	0.000449	0.0113	CcSEcCtD
Adapalene—Feeling hot—Doxorubicin—thyroid cancer	0.000448	0.0113	CcSEcCtD
Adapalene—Rash pustular—Doxorubicin—thyroid cancer	0.00044	0.0111	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000435	0.00336	CbGpPWpGaD
Adapalene—Stinging—Doxorubicin—thyroid cancer	0.000434	0.0109	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000433	0.00335	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000433	0.00335	CbGpPWpGaD
Adapalene—Skin discolouration—Epirubicin—thyroid cancer	0.00042	0.0106	CcSEcCtD
Adapalene—Herpes simplex—Epirubicin—thyroid cancer	0.000412	0.0104	CcSEcCtD
Adapalene—Angioedema—Sorafenib—thyroid cancer	0.00041	0.0103	CcSEcCtD
Adapalene—Skin discolouration—Doxorubicin—thyroid cancer	0.000389	0.00981	CcSEcCtD
Adapalene—RXRG—Adipogenesis—RXRA—thyroid cancer	0.000388	0.003	CbGpPWpGaD
Adapalene—Pruritus—Vandetanib—thyroid cancer	0.000384	0.00969	CcSEcCtD
Adapalene—Herpes simplex—Doxorubicin—thyroid cancer	0.000381	0.00961	CcSEcCtD
Adapalene—Dermatitis contact—Epirubicin—thyroid cancer	0.000375	0.00946	CcSEcCtD
Adapalene—RARA—Adipogenesis—RXRA—thyroid cancer	0.000364	0.00282	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000364	0.00282	CbGpPWpGaD
Adapalene—Skin exfoliation—Epirubicin—thyroid cancer	0.000362	0.00914	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—thyroid cancer	0.000347	0.00875	CcSEcCtD
Adapalene—Rash—Vandetanib—thyroid cancer	0.000343	0.00864	CcSEcCtD
Adapalene—Dermatitis—Vandetanib—thyroid cancer	0.000342	0.00863	CcSEcCtD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000342	0.00265	CbGpPWpGaD
Adapalene—Skin exfoliation—Doxorubicin—thyroid cancer	0.000335	0.00846	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—THRB—thyroid cancer	0.000333	0.00258	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—THRB—thyroid cancer	0.000327	0.00253	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—PPARG—thyroid cancer	0.000321	0.00248	CbGpPWpGaD
Adapalene—Pain—Sorafenib—thyroid cancer	0.000313	0.0079	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—THRB—thyroid cancer	0.000313	0.00242	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—THRB—thyroid cancer	0.000313	0.00242	CbGpPWpGaD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000313	0.00242	CbGpPWpGaD
Adapalene—RXRA—PPAR Alpha Pathway—CCND1—thyroid cancer	0.000309	0.00239	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000307	0.00237	CbGpPWpGaD
Adapalene—Eczema—Epirubicin—thyroid cancer	0.000307	0.00773	CcSEcCtD
Adapalene—Eye pain—Epirubicin—thyroid cancer	0.000305	0.0077	CcSEcCtD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000294	0.00228	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000294	0.00228	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000292	0.00737	CcSEcCtD
Adapalene—Urticaria—Sorafenib—thyroid cancer	0.000291	0.00734	CcSEcCtD
Adapalene—Dermatitis bullous—Epirubicin—thyroid cancer	0.000288	0.00727	CcSEcCtD
Adapalene—RXRG—Adipogenesis—HIF1A—thyroid cancer	0.000288	0.00223	CbGpPWpGaD
Adapalene—Eczema—Doxorubicin—thyroid cancer	0.000284	0.00716	CcSEcCtD
Adapalene—Eye pain—Doxorubicin—thyroid cancer	0.000282	0.00712	CcSEcCtD
Adapalene—RXRA—Circadian Clock—HIF1A—thyroid cancer	0.000281	0.00217	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000279	0.00216	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—HIF1A—thyroid cancer	0.000271	0.00209	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00027	0.00682	CcSEcCtD
Adapalene—Hypersensitivity—Sorafenib—thyroid cancer	0.00027	0.00681	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000268	0.00207	CbGpPWpGaD
Adapalene—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000267	0.00673	CcSEcCtD
Adapalene—Face oedema—Epirubicin—thyroid cancer	0.000266	0.00671	CcSEcCtD
Adapalene—Pruritus—Sorafenib—thyroid cancer	0.000259	0.00654	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000256	0.00198	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000254	0.00196	CbGpPWpGaD
Adapalene—Dry skin—Epirubicin—thyroid cancer	0.000253	0.00637	CcSEcCtD
Adapalene—Face oedema—Doxorubicin—thyroid cancer	0.000246	0.00621	CcSEcCtD
Adapalene—RXRG—Adipogenesis—PPARG—thyroid cancer	0.000245	0.00189	CbGpPWpGaD
Adapalene—RARG—Gene Expression—TRIM33—thyroid cancer	0.000243	0.00188	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000241	0.00186	CbGpPWpGaD
Adapalene—Dry skin—Doxorubicin—thyroid cancer	0.000234	0.00589	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000231	0.00179	CbGpPWpGaD
Adapalene—Rash—Sorafenib—thyroid cancer	0.000231	0.00583	CcSEcCtD
Adapalene—Dermatitis—Sorafenib—thyroid cancer	0.000231	0.00582	CcSEcCtD
Adapalene—RARA—Adipogenesis—PPARG—thyroid cancer	0.00023	0.00178	CbGpPWpGaD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000226	0.00175	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000226	0.00175	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—TRIM33—thyroid cancer	0.000222	0.00172	CbGpPWpGaD
Adapalene—RARB—Gene Expression—TRIM33—thyroid cancer	0.000218	0.00168	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000217	0.00548	CcSEcCtD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000213	0.00165	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000212	0.00164	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—TRIM33—thyroid cancer	0.000209	0.00161	CbGpPWpGaD
Adapalene—RARA—Gene Expression—TRIM33—thyroid cancer	0.000209	0.00161	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000208	0.00161	CbGpPWpGaD
Adapalene—Conjunctivitis—Epirubicin—thyroid cancer	0.000206	0.00521	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—SLC5A5—thyroid cancer	0.000206	0.00159	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000201	0.00507	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000199	0.00154	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MEN1—thyroid cancer	0.000199	0.00154	CbGpPWpGaD
Adapalene—Conjunctivitis—Doxorubicin—thyroid cancer	0.000191	0.00482	CcSEcCtD
Adapalene—Hepatitis—Epirubicin—thyroid cancer	0.000191	0.00481	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—thyroid cancer	0.000182	0.00141	CbGpPWpGaD
Adapalene—Hepatitis—Doxorubicin—thyroid cancer	0.000176	0.00445	CcSEcCtD
Adapalene—RARG—Gene Expression—THRB—thyroid cancer	0.000175	0.00136	CbGpPWpGaD
Adapalene—Erythema—Epirubicin—thyroid cancer	0.000166	0.00419	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—THRB—thyroid cancer	0.000163	0.00126	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000161	0.00125	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—THRB—thyroid cancer	0.00016	0.00124	CbGpPWpGaD
Adapalene—RARB—Gene Expression—THRB—thyroid cancer	0.000157	0.00122	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000155	0.0012	CbGpPWpGaD
Adapalene—Erythema—Doxorubicin—thyroid cancer	0.000154	0.00387	CcSEcCtD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000153	0.00119	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—THRB—thyroid cancer	0.000151	0.00117	CbGpPWpGaD
Adapalene—RARA—Gene Expression—THRB—thyroid cancer	0.000151	0.00117	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—NRG1—thyroid cancer	0.00015	0.00116	CbGpPWpGaD
Adapalene—Convulsion—Epirubicin—thyroid cancer	0.000144	0.00363	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000142	0.0011	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—HIF1A—thyroid cancer	0.000141	0.00109	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—RXRA—thyroid cancer	0.000139	0.00107	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000139	0.00107	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—PPARG—thyroid cancer	0.000137	0.00106	CbGpPWpGaD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000134	0.00104	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—RXRA—thyroid cancer	0.000133	0.00103	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—RXRA—thyroid cancer	0.000133	0.00103	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000133	0.00103	CbGpPWpGaD
Adapalene—Convulsion—Doxorubicin—thyroid cancer	0.000133	0.00336	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000125	0.000971	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000125	0.000971	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000121	0.000937	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00012	0.000931	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—PPARG—thyroid cancer	0.00012	0.000928	CbGpPWpGaD
Adapalene—RARG—Gene Expression—TPR—thyroid cancer	0.000118	0.000917	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000116	0.000898	CbGpPWpGaD
Adapalene—Pain—Epirubicin—thyroid cancer	0.000116	0.00292	CcSEcCtD
Adapalene—RXRA—Metabolism—MINPP1—thyroid cancer	0.000112	0.000863	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MEN1—thyroid cancer	0.000111	0.000862	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000111	0.000857	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—TRIM33—thyroid cancer	0.000109	0.000841	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—TPR—thyroid cancer	0.000108	0.000839	CbGpPWpGaD
Adapalene—Urticaria—Epirubicin—thyroid cancer	0.000108	0.00271	CcSEcCtD
Adapalene—Pain—Doxorubicin—thyroid cancer	0.000107	0.0027	CcSEcCtD
Adapalene—RARB—Gene Expression—TPR—thyroid cancer	0.000106	0.000822	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MEN1—thyroid cancer	0.000104	0.000802	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—TPR—thyroid cancer	0.000102	0.000788	CbGpPWpGaD
Adapalene—RARA—Gene Expression—TPR—thyroid cancer	0.000102	0.000788	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MEN1—thyroid cancer	0.000102	0.000788	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MEN1—thyroid cancer	9.99e-05	0.000773	CbGpPWpGaD
Adapalene—Hypersensitivity—Epirubicin—thyroid cancer	9.98e-05	0.00252	CcSEcCtD
Adapalene—Urticaria—Doxorubicin—thyroid cancer	9.96e-05	0.00251	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—PPARG—thyroid cancer	9.77e-05	0.000756	CbGpPWpGaD
Adapalene—Pruritus—Epirubicin—thyroid cancer	9.58e-05	0.00242	CcSEcCtD
Adapalene—RXRB—Gene Expression—MEN1—thyroid cancer	9.58e-05	0.000741	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MEN1—thyroid cancer	9.58e-05	0.000741	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NDUFA13—thyroid cancer	9.48e-05	0.000734	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	9.29e-05	0.000719	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	9.24e-05	0.000715	CbGpPWpGaD
Adapalene—Hypersensitivity—Doxorubicin—thyroid cancer	9.23e-05	0.00233	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—PPARG—thyroid cancer	8.94e-05	0.000692	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CHST14—thyroid cancer	8.92e-05	0.00069	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	8.91e-05	0.00069	CbGpPWpGaD
Adapalene—Pruritus—Doxorubicin—thyroid cancer	8.87e-05	0.00224	CcSEcCtD
Adapalene—RXRA—Transmembrane transport of small molecules—TPR—thyroid cancer	8.81e-05	0.000682	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—CP—thyroid cancer	8.81e-05	0.000682	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—PPARG—thyroid cancer	8.76e-05	0.000678	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.67e-05	0.000671	CbGpPWpGaD
Adapalene—Rash—Epirubicin—thyroid cancer	8.54e-05	0.00215	CcSEcCtD
Adapalene—Dermatitis—Epirubicin—thyroid cancer	8.53e-05	0.00215	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—PPARG—thyroid cancer	8.4e-05	0.00065	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—PPARG—thyroid cancer	8.4e-05	0.00065	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.26e-05	0.000639	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	7.92e-05	0.000613	CbGpPWpGaD
Adapalene—Rash—Doxorubicin—thyroid cancer	7.9e-05	0.00199	CcSEcCtD
Adapalene—Dermatitis—Doxorubicin—thyroid cancer	7.89e-05	0.00199	CcSEcCtD
Adapalene—RXRA—Gene Expression—THRB—thyroid cancer	7.86e-05	0.000608	CbGpPWpGaD
Adapalene—RARG—Gene Expression—RXRA—thyroid cancer	7.45e-05	0.000577	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HPGD—thyroid cancer	7.19e-05	0.000556	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CDK1—thyroid cancer	7.03e-05	0.000544	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.98e-05	0.00054	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	6.94e-05	0.000537	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—RXRA—thyroid cancer	6.82e-05	0.000527	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.69e-05	0.000518	CbGpPWpGaD
Adapalene—RARB—Gene Expression—RXRA—thyroid cancer	6.68e-05	0.000517	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.6e-05	0.000511	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—RXRA—thyroid cancer	6.41e-05	0.000496	CbGpPWpGaD
Adapalene—RARA—Gene Expression—RXRA—thyroid cancer	6.41e-05	0.000496	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	6.27e-05	0.000485	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	6.05e-05	0.000468	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—TPR—thyroid cancer	5.31e-05	0.000411	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MEN1—thyroid cancer	4.99e-05	0.000386	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PPARG—thyroid cancer	4.7e-05	0.000364	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.64e-05	0.000359	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—PPARG—thyroid cancer	4.38e-05	0.000339	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PPARG—thyroid cancer	4.3e-05	0.000333	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PPARG—thyroid cancer	4.22e-05	0.000327	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TPR—thyroid cancer	4.13e-05	0.00032	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.13e-05	0.000319	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PPARG—thyroid cancer	4.12e-05	0.000319	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PRKAR1A—thyroid cancer	4.06e-05	0.000314	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PPARG—thyroid cancer	4.05e-05	0.000313	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PPARG—thyroid cancer	4.05e-05	0.000313	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.68e-05	0.000285	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.49e-05	0.00027	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC5A5—thyroid cancer	3.09e-05	0.000239	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.9e-05	0.000224	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.53e-05	0.000195	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NRAS—thyroid cancer	2.52e-05	0.000195	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KRAS—thyroid cancer	2.17e-05	0.000168	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PPARG—thyroid cancer	2.11e-05	0.000163	CbGpPWpGaD
Adapalene—RARG—Gene Expression—AKT1—thyroid cancer	1.86e-05	0.000144	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HRAS—thyroid cancer	1.85e-05	0.000143	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—AKT1—thyroid cancer	1.7e-05	0.000132	CbGpPWpGaD
Adapalene—RARB—Gene Expression—AKT1—thyroid cancer	1.67e-05	0.000129	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PPARG—thyroid cancer	1.64e-05	0.000127	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—AKT1—thyroid cancer	1.63e-05	0.000126	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—AKT1—thyroid cancer	1.6e-05	0.000124	CbGpPWpGaD
Adapalene—RARA—Gene Expression—AKT1—thyroid cancer	1.6e-05	0.000124	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—thyroid cancer	1.29e-05	9.98e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTEN—thyroid cancer	1.12e-05	8.7e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AKT1—thyroid cancer	8.34e-06	6.45e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKT1—thyroid cancer	6.48e-06	5.02e-05	CbGpPWpGaD
